Pro-Tumorigenic Signaling Between Small Extracellular Vesicles of Cancer Cells and Bone Marrow-Derived Mesenchymal Stem Cells—An In Vitro Study
International Journal of Molecular Sciences · 13.03.2026 · 27 (6) · 2654
DOI: 10.3390/ijms27062654 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.03.2026. Verfasst von Jyothi Attem und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, Science Complex, University of Hyderabad, Hyderabad 500046, India. Hauptthemen laut MEDLINE: Retinoblastoma, Extracellular Vesicles, Mesenchymal Stem Cells, Bone Marrow Cells. Die Arbeit nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Engineering Research 571 Board, Institution of Eminence, Council of Scientific and Industrial Research (CSIR).
Abstract (Originalsprache)
Retinoblastoma (Rb) is an intraocular tumor caused by genetic alterations in the RB1 and MYCN genes within developing retinal cells. Chemoresistance and metastasis are major challenges for treatment, with the bone marrow (BM) representing the most common metastatic site. We investigated the effect of tumor-derived sEVs (TDsEVs) on the crosstalk between metastatic site cells (BM-derived mesenchymal stem cells (BM-MSC)) and tumor cells, and characterized them according to MISEV guidelines. The uptake of sEVs and the associated phenotypic changes in the BM-MSCs were analyzed with confocal microcopy. The functional effects were assessed through MTT assays for viability, scratch and Transwell assays for migration, and colony- and sphere-formation assays to evaluate clonogenicity and self-renewal, while stemness marker expression was examined by immunoblotting. Secretome changes following sEV exposure were analyzed using dot blot assays. sEVs were taken up by both cells. TD-sEVs significantly enhanced BM-MSC migration and induced differentiation into a myofibroblast-like phenotype without affecting cell viability. Conversely, BM-MSC-derived sEVs promoted tumor cell viability, migration, and stemness marker expression. Both the BM-MSCs and tumor cells exhibited altered secretory profiles after sEV treatment. The in vitro findings provide cumulative evidence that sEV-mediated interactions contribute to a tumor-supportive milieu or premetastatic niche at the BM in Rb.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medical Sciences, Science Complex, University of Hyderabad, Hyderabad 500046, India.
- L.V Prasad Eye Institute, Hyderabad 500034, India.
- The Operation Eyesight Universal Institute for Eye Cancers, L.V Prasad Eye Institute, Hyderabad 500034, India.
- Prof. Brien Holden Eye Research Centre, L.V Prasad Eye Institute, Hyderabad 500034, India.
ORCID-Profile: Jyothi Attem, Swathi Kaliki
Förderung
- Science and Engineering Research 571 Board
- Institution of Eminence
- Council of Scientific and Industrial Research (CSIR)
- Indian council of Medical Research (ICMR)
- Prateek Menezes Memorial Goa, India, along with Hyderabad Eye 574 Research Foundation (HERF)
Zitieren
APA
Attem, J., Jogula, R. M. R., Kaliki, S., & Vemuganti, G. K. (2026). Pro-Tumorigenic Signaling Between Small Extracellular Vesicles of Cancer Cells and Bone Marrow-Derived Mesenchymal Stem Cells—An In Vitro Study. International Journal of Molecular Sciences, 27(6), 2654. https://doi.org/10.3390/ijms27062654
Vancouver
Attem J, Jogula RMR, Kaliki S, Vemuganti GK. Pro-Tumorigenic Signaling Between Small Extracellular Vesicles of Cancer Cells and Bone Marrow-Derived Mesenchymal Stem Cells—An In Vitro Study. International Journal of Molecular Sciences. 2026;27(6):2654. doi:10.3390/ijms27062654
BibTeX
@article{Attem2026,
author = {Attem, Jyothi and Jogula, Ram Mukka Raju and Kaliki, Swathi and Vemuganti, Geeta K},
title = {Pro-Tumorigenic Signaling Between Small Extracellular Vesicles of Cancer Cells and Bone Marrow-Derived Mesenchymal Stem Cells—An In Vitro Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {6},
pages = {2654},
doi = {10.3390/ijms27062654}
}
EUVIMED